Cici Liu, MD
Gynecological Oncology · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Offices
- 2
Offices
2 locations · Bay Area Gynecology Oncology Inc · Svmhs Clinics
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital · Salinas Valley Health Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A181570 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · Northwestern University Feinberg School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$136,524
Medicare paid this office $136,524 for 125 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 96 | $19,827 | $107 |
| Long return visit (40+ min) | 53 | $13,426 | $158 |
| New patient visit (60+ min) | 49 | $9,187 | $187 |
| Pelvic exam | 98 | $4,498 | $23 |
| Exam of external female genitals using an endoscope | 11 | $2,096 | $116 |
See all 8 services
| Return visit (30+ min) | 96 | $19,827 | $107 |
| Long return visit (40+ min) | 53 | $13,426 | $158 |
| New patient visit (60+ min) | 49 | $9,187 | $187 |
| Pelvic exam | 98 | $4,498 | $23 |
| Exam of external female genitals using an endoscope | 11 | $2,096 | $116 |
| Short return visit (20+ min) | 15 | $1,427 | $79 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 19 | $631 | $29 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $254 | $15 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of the uterus | 32 | More than 97% of doctors who do this |
Who their Medicare patients are
125 Original Medicare patients in 2024. Average age 73 · Women 100% · Also on Medicaid 24% · Health risk score 1.12. At or below the middle of the specialty; the typical gynecological oncology clinician is at 1.53.
Conditions among them: High blood pressure 70% · Cancer 42% · Diabetes 30% · Coronary heart disease 18% · Chronic kidney disease 18% · Atrial fibrillation 16% · Heart failure 10% · COPD 10% · Depression 9%.
The office billed $753,402, Medicare allowed $175,676 and paid $136,524; for 815 services of 98 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 125 | 815 | 73 | 1.12 | $753,402 | $136,524 |
| 2023 | 92 | 366 | 72 | 1.43 | $417,293 | $82,064 |
| 2022 | 84 | 311 | 71 | 2.11 | $192,520 | $39,151 |
| 2021 | 81 | 337 | 69 | 1.90 | $262,040 | $45,808 |
| 2020 | 80 | 351 | 69 | 1.85 | $287,675 | $47,241 |
| 2019 | 25 | 70 | 68 | 1.19 | $69,105 | $12,103 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| New patient visit (60+ min) | 48 | $9,651 | $201 |
| Long return visit (40+ min) | 29 | $8,040 | $161 |
| Return visit (30+ min) | 44 | $7,226 | $106 |
| Short return visit (20+ min) | 18 | $2,011 | $84 |
2022: 6 services
| Long return visit (40+ min) | 43 | $9,346 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,284 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,522 | $80 |
| Return visit (30+ min) | 17 | $1,245 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $1,029 | $30 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 16 | $579 | $24 |
2021: 5 services
| Long return visit (40+ min) | 46 | $16,627 | $127 |
| Return visit (30+ min) | 28 | $3,627 | $93 |
| New patient visit (60+ min) | 16 | $2,378 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $954 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $570 | $30 |
2020: 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 12 | $7,653 | $638 |
| Long return visit (40+ min) | 20 | $5,947 | $114 |
| New patient visit (60+ min) | 29 | $4,283 | $148 |
| Return visit (30+ min) | 21 | $2,810 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,376 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,648 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,444 | $30 |
| Short return visit (20+ min) | 12 | $1,053 | $55 |
2019: 1 service
| New patient visit (60+ min) | 17 | $2,686 | $158 |
Medicaid work
$759 in 2024
Medicaid paid $759 for 16 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 16 | $759 |
| 2024 | 16 | 1 | 13 | $759 |
| 2023 | 13 | 1 | 12 | $442 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 13 | $442 |
Drugs they prescribed that Part D paid
$13,357
Pharmacies billed $13,357 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 13% of their Part D prescriptions (29 of 232) in 2024. At or below the middle of the specialty; the typical gynecological oncology clinician is at 13%.
214 generic and 18 brand-name prescriptions · $13,357 in drug cost · 14 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 37 | $2,127 | $57 |
| Clobetasol Propionate | 12 | $565 | $47 |
| Celecoxib | 32 | $543 | $17 |
| Nystatin | 14 | $248 | $18 |
| Imiquimod | 13 | $174 | $13 |
See all 6 drugs
| Estradiol | 37 | $2,127 | $57 |
| Clobetasol Propionate | 12 | $565 | $47 |
| Celecoxib | 32 | $543 | $17 |
| Nystatin | 14 | $248 | $18 |
| Imiquimod | 13 | $174 | $13 |
| Oxycodone | 27 | $154 | $6 |
Year by year
| 2024 | 232 | 87 | 13% (29) | 8% | $13,357 |
| 2023 | 180 | 80 | 23% (42) | 13% | $31,694 |
| 2022 | 132 | 49 | None | 19% | $258,374 |
| 2021 | 268 | 69 | None | 17% | $541,663 |
| 2020 | 156 | 52 | None | 11% | $28,688 |
| 2019 | 86 | 42 | 62% (53) | None | $49,903 |
| 2018 | 45 | 30 | 87% (39) | None | $2,116 |
| 2017 | 22 | 14 | None | None | $1,477 |
| 2016 | 63 | 35 | 95% (60) | None | $2,385 |
| 2015 | 51 | 32 | 78% (40) | None | $1,938 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Celecoxib | 36 | $699 | $19 |
| Oxycodone | 42 | $121 | $3 |
| Ibuprofen | 18 | $78 | $4 |
2022: 1 drug
| Ondansetron | 20 | $425 | $21 |
2021: 6 drugs
| Lenvima | 19 | $393,090 | $20,689 |
| Megestrol Acetate | 13 | $680 | $52 |
| Prochlorperazine Maleate | 27 | $353 | $13 |
| Ondansetron | 21 | $186 | $9 |
| Gabapentin | 20 | $162 | $8 |
| Letrozole | 18 | $77 | $4 |
2020: 4 drugs
| Megestrol Acetate | 17 | $1,737 | $102 |
| Prochlorperazine Maleate | 29 | $481 | $17 |
| Ondansetron | 16 | $162 | $10 |
| Gabapentin | 13 | $75 | $6 |
2019: 2 drugs
| Hydrocodone-Acetaminophen | 20 | $410 | $20 |
| Oxycodone | 19 | $152 | $8 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 21 | $315 | $15 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 43 | $1,063 | $25 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 27 | $494 | $18 |
Money from drug and device companies
$4,551 in 2025
| 2025 | 16 | 36 | None | $4,551 |
| 2024 | 12 | 23 | None | $2,086 |
| 2023 | 9 | 15 | None | $593 |
| 2019 | 1 | 1 | None | $102 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Davinci Xi | $3,662 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $200 | 4 payments
|
| Eisai | Lenvima | $115 | 4 payments
|
| Sumitomo Pharma America | Myfembree | $98 | 4 payments
|
| Smith+Nephew | Stravix | $96 | 2 payments
|
| Bluewind Medical | Revi | $82 | 3 payments
|
See all 36 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-04 | Lynparza | $121 |
| Sumitomo Pharma America | Meals · 2025-12-01 | Myfembree | $24 |
| Baxter Healthcare | Meals · 2025-11-24 | Floseal | $31 |
| Intuitive Surgical | Education · 2025-11-21 | Davinci Xi | $1,500 |
| Astellas Pharma US | Meals · 2025-11-19 | Veozah | $26 |
| Intuitive Surgical | Meals · 2025-11-17 | Da Vinci Surgical System | $28 |
| Intuitive Surgical | Education · 2025-11-17 | Davinci Xi | $1,000 |
| Merck Sharp & Dohme | Meals · 2025-10-06 | Keytruda | $26 |
| Ethicon US | Meals · 2025-09-26 | Stratafix | $23 |
| Smith+Nephew | Meals · 2025-09-16 | Stravix | $48 |
| Bluewind Medical | Meals · 2025-08-19 | Revi | $29 |
| Eisai | Meals · 2025-08-18 | Lenvima | $24 |
| Abbvie | Meals · 2025-08-07 | Botox | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-05 | None | $31 |
| Smith+Nephew | Meals · 2025-07-30 | Stravix | $48 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-28 | None | $26 |
| Sumitomo Pharma America | Meals · 2025-07-09 | Gemtesa | $37 |
| Eisai | Meals · 2025-07-07 | Lenvima | $32 |
| Coloplast | Meals · 2025-07-03 | Altis | $14 |
| Astellas Pharma US | Meals · 2025-06-24 | Veozah | $19 |
| Tempus AI | Meals · 2025-06-13 | Xt Cdx | $19 |
| Sumitomo Pharma America | Meals · 2025-06-09 | Myfembree | $22 |
| Intuitive Surgical | Meals · 2025-06-07 | Da Vinci Surgical System | $368 |
| Bluewind Medical | Meals · 2025-06-04 | Revi | $25 |
| Intuitive Surgical | Travel · 2025-06-04 | Da Vinci Surgical System | $19 |
| Intuitive Surgical | Travel · 2025-06-04 | Da Vinci Surgical System | $362 |
| Intuitive Surgical | Travel · 2025-06-04 | Da Vinci Surgical System | $384 |
| Eisai | Meals · 2025-05-05 | Lenvima | $31 |
| Bluewind Medical | Meals · 2025-04-23 | Revi | $28 |
| Biotissue Holdings | Meals · 2025-04-17 | None | $18 |
| Minerva Surgical | Meals · 2025-04-16 | None | $36 |
| Astellas Pharma US | Meals · 2025-04-15 | Veozah | $19 |
| Sumitomo Pharma America | Meals · 2025-03-24 | Myfembree | $15 |
| Hologic Sales and Service | Meals · 2025-03-03 | Acessa Provu System | $35 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-24 | Lynparza | $23 |
| Eisai | Meals · 2025-01-27 | Lenvima | $28 |
See earlier years (2024, 2023, 2019)
2024: $2,086
| Medical Device Business Services | Enseal | $1,332 | 6 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $217 | 4 payments
|
| Dilon Technologies | Hemoblast Bellows | $148 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $118 | 4 payments
|
| Conmed | Airseal | $100 | 1 payment
|
| Ethicon US | Harmonic | $40 | 1 payment
|
| Eisai | Lenvima | $35 | 1 payment
|
| Baxter Healthcare | Perclot | $27 | 1 payment
|
| Myriad Genetic Laboratories | Precisetumor | $21 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $19 | 1 payment
|
| Coloplast | Altis | $15 | 1 payment
|
| Agile Therapeutics | Twirla | $15 | 1 payment
|
2023: $593
| Myriad Genetic Laboratories | Precisetumor | $185 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $124 | 2 payments
|
| Ethicon US | Echelon Circular | $103 | 2 payments
|
| Conmed | Airseal | $68 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $25 | 1 payment
|
| Biotissue Holdings | Neox | $23 | 1 payment
|
| Medtronic | Interstim | $23 | 1 payment
|
| Seagen | Tivdak | $23 | 1 payment
|
| Heron Therapeutics | Zynrelef | $19 | 1 payment
|
2019: $102
| Genentech USA | Avastin | $102 | 1 payment
|
Professional record
- NPI
- 1952620577
- Licence
- CA A181570, NY 274447California A181570: Current · expires 2028-08-31
- Trained
- Northwestern University Feinberg Medical School, 2010
- Group
- Bay Area Gynecology Oncology Inc · Svmhs Clinics
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VX0201X (207VX0201X)
- Mailing address
- 601 Elmwood Ave Box 668, Rochester, NY, 14642
- NPI first listed
- 2010-05-21
- NPI last updated
- 2023-06-29
- NPI record certified
- 2023-02-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 250 San Jose St, Salinas, CA, 93901
This office lists an electronic records connection.